Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
3,57 CAD | +1,13 % | +10,87 % | +224,55 % |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
David Elsley
FOU | Founder | - | 19/01/17 |
Director of Finance/CFO | - | 16/08/18 | |
Kelly Narine
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/20 |
Andrew Hamer
CTO | Chief Tech/Sci/R&D Officer | 62 | 29/03/21 |
Bernard Lim
COO | Chief Operating Officer | - | 03/12/20 |
Trevor Burns
IRC | Investor Relations Contact | - | 01/01/17 |
John Geddes
PRN | Corporate Officer/Principal | - | 01/01/22 |
Corporate Officer/Principal | - | 01/06/15 | |
Thomas Moffatt
PRN | Corporate Officer/Principal | - | 01/03/19 |
Anne Tomalin
LAW | General Counsel | - | 01/04/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
David Elsley
FOU | Founder | - | 19/01/17 |
Jennifer Chao
BRD | Director/Board Member | 54 | 15/03/22 |
Michael Willner
BRD | Director/Board Member | 57 | 07/09/21 |
Director of Finance/CFO | - | 16/08/18 | |
Peter Pekos
BRD | Director/Board Member | - | 15/12/17 |
Chairman | - | 20/08/18 | |
Teri Loxam
BRD | Director/Board Member | 52 | 19/05/22 |
Colin Stott
BRD | Director/Board Member | 57 | 03/12/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 68 373 313 | 65 254 138 ( 95,44 %) | 0 | 95,44 % |
Información de la empresa
Cardiol Therapeutics, Inc.
2265 Upper Middle Road East Suite 602
L6H 0G5, Oakville
+289-910-0850
http://www.cardiolrx.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+224,55 % | 179 M | |
+43,36 % | 54,63 mil M | |
-5,31 % | 39,92 mil M | |
+14,75 % | 26,86 mil M | |
-12,56 % | 26,22 mil M | |
-22,45 % | 18,78 mil M | |
+25,12 % | 12,21 mil M | |
+0,04 % | 12,16 mil M | |
+26,04 % | 11,94 mil M | |
-11,83 % | 10,74 mil M |
- Bolsa de valores
- Acciones
- Acción CRDL
- Empresa Cardiol Therapeutics Inc.